Clinical Trials Browser

Phase 4 × Prostatic Neoplasms × Docetaxel × Clear all

NCT00280098 2009-12-07

Docetaxel in the Treatment of Hormone Refractory Prostate Cancer

Phase 4 Completed

Prostatic Neoplasms